Targeting intracellular B2 receptors using novel cell-penetrating antagonists to arrest growth and induce apoptosis in human triple-negative breast cancer-Reference-Cited by-同舟云学术

Targeting intracellular B2 receptors using novel cell-penetrating antagonists to arrest growth and induce apoptosis in human triple-negative breast cancer

Published:2018-01-05 Issue:11 Volume:9 Page:9885-9906
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Dubuc Céléna¹²,Savard Martin¹²,Bovenzi Veronica¹²,Lessard Andrée³,Fortier Audrey¹²,Côté Jérôme¹²,Neugebauer Witold¹²,Rizzolio Flavio⁴⁵,Geha Sameh⁶,Giordano Antonio⁴,Chemtob Sylvain⁷,Gobeil Fernand¹²

Affiliation:

1. Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec, Canada

2. Institute of Pharmacology, Université de Sherbrooke, Sherbrooke, Québec, Canada

3. Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, United States

4. Department of Biology, Sbarro Institute for Cancer Research and Molecular Medicine, Temple University, Philadelphia, PA, USA

5. Dipartimento di Scienze Molecolari e Nanosistemi, Università Ca' Foscari Venezia, Mestre-Venezia, Italy

6. Department of Pathology, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Québec, Canada

7. Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine Research Center, Montréal, Québec, Canada

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deep Learning-Based, Multiclass Approach to Cancer Classification on Liquid Biopsy Data;IEEE Journal of Translational Engineering in Health and Medicine;2024

2. Facts and prospects of peptide in targeted therapy and immune regulation against triple-negative breast cancer;Frontiers in Immunology;2023-08-25

3. Targeting c-Jun Is a Potential Therapy for Luminal Breast Cancer Bone Metastasis;Molecular Cancer Research;2023-06-13

4. Kinin B1 and B2 receptors mediate cancer pain associated with both the tumor and oncology therapy using aromatase inhibitors;Scientific Reports;2023-03-17

5. Development of a multigram synthesis of the bradykinin receptor 2 agonist FR‐190997 and analogs thereof;Archiv der Pharmazie;2023-01-31